[go: up one dir, main page]

MX9805441A - Compuestos terapeuticos. - Google Patents

Compuestos terapeuticos.

Info

Publication number
MX9805441A
MX9805441A MX9805441A MX9805441A MX9805441A MX 9805441 A MX9805441 A MX 9805441A MX 9805441 A MX9805441 A MX 9805441A MX 9805441 A MX9805441 A MX 9805441A MX 9805441 A MX9805441 A MX 9805441A
Authority
MX
Mexico
Prior art keywords
therapeutic compounds
relates
benzimidazole derivatives
prophylaxis
preparation
Prior art date
Application number
MX9805441A
Other languages
English (en)
Inventor
Stanley Dawes Chamberlain
George Walter Koszalka
Jeffrey H Tidwell
Nanine Agneta Van Draanen
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MX9805441A publication Critical patent/MX9805441A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invencion se refiere a derivados de bencimidazol y su uso en terapia médica particularmente para el tratamiento o profilaxis de infecciones de virus tal como aquellos provocados por el virus de herpes. La invencion también se refiere a la preparacion de derivados de bencimidazol y formulaciones farmacéuticas que los contienen.
MX9805441A 1996-01-05 1998-07-03 Compuestos terapeuticos. MX9805441A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600143.3A GB9600143D0 (en) 1996-01-05 1996-01-05 Therapeutic compounds

Publications (1)

Publication Number Publication Date
MX9805441A true MX9805441A (es) 1998-11-30

Family

ID=10786611

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9805441A MX9805441A (es) 1996-01-05 1998-07-03 Compuestos terapeuticos.

Country Status (21)

Country Link
US (2) US6204249B1 (es)
EP (1) EP0876389A1 (es)
JP (1) JP2000515119A (es)
KR (1) KR19990077041A (es)
CN (1) CN1214049A (es)
AP (1) AP9801286A0 (es)
AU (1) AU729541B2 (es)
BR (1) BR9612413A (es)
CA (1) CA2241993A1 (es)
CZ (1) CZ212698A3 (es)
EA (1) EA001770B1 (es)
GB (1) GB9600143D0 (es)
HU (1) HUP9904301A3 (es)
IS (1) IS4789A (es)
MX (1) MX9805441A (es)
NO (1) NO983090L (es)
NZ (1) NZ324380A (es)
OA (1) OA10707A (es)
PL (1) PL327732A1 (es)
TR (1) TR199801289T2 (es)
WO (1) WO1997025337A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2186799T3 (es) * 1995-08-18 2003-05-16 Univ Michigan Bencimidazoles sustituidos en 5' utilizados como agentes antivirales.
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
DE69819695D1 (en) 1997-02-13 2003-12-18 Glaxo Group Ltd Benzimidazolderivate
CA2281927C (en) 1997-02-25 2004-01-27 Christopher J. Michejda Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
JP2001512132A (ja) 1997-07-30 2001-08-21 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン 抗ウイルス薬としてのリクソフラノシルベンズイミダゾール
GB9807355D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
CA2550441C (en) 2003-12-26 2012-08-28 Kissei Pharmaceutical Co., Ltd. Benzimidazole derivatives and medical uses thereof
EP2210896A1 (en) * 2007-10-05 2010-07-28 API Corporation Process for production of ribofuranose derivatives
CN114096549A (zh) * 2020-06-23 2022-02-25 博美利克斯技术公司 新型苯并咪唑衍生物、其制备方法及其作为抗癌剂或者抗病毒剂的用途
EP4480956A3 (en) 2022-10-12 2025-02-19 Takeda Pharmaceutical Company Limited Viral inhibitors, the synthesis thereof, and intermediates thereto
WO2024103979A1 (zh) * 2022-11-17 2024-05-23 北京凯因科技股份有限公司 一种抑制疱疹病毒的化合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE130030C (es)
US3399987A (en) 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
US4002623A (en) 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
FR2551442B1 (fr) 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
EP0304624A3 (de) 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Benzimidazol-2-yl-pyridiniumverbindungen
IT1226100B (it) 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
SE9003151D0 (sv) 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1992018517A1 (en) 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
ZA923640B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
AU5447094A (en) 1992-10-21 1994-05-09 Regents Of The University Of Michigan, The Polysubstituted benzimidazoles as antiviral agents
GB9226879D0 (en) 1992-12-23 1993-02-17 Iaf Biochem Int Anti-viral compounds
US5399580A (en) 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
ES2186799T3 (es) 1995-08-18 2003-05-16 Univ Michigan Bencimidazoles sustituidos en 5' utilizados como agentes antivirales.
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
US5995610A (en) * 1997-05-06 1999-11-30 Telefonaktiebolaget Lm Ericsson Cooperative call processing across public and private intelligent networks

Also Published As

Publication number Publication date
NZ324380A (en) 2000-01-28
AU729541B2 (en) 2001-02-01
IS4789A (is) 1998-06-30
WO1997025337A1 (en) 1997-07-17
KR19990077041A (ko) 1999-10-25
EA001770B1 (ru) 2001-08-27
PL327732A1 (en) 1998-12-21
HUP9904301A2 (hu) 2000-05-28
HUP9904301A3 (en) 2001-07-30
US6617315B1 (en) 2003-09-09
NO983090L (no) 1998-09-01
EP0876389A1 (en) 1998-11-11
CZ212698A3 (cs) 1998-12-16
AU1164097A (en) 1997-08-01
OA10707A (en) 2001-05-09
BR9612413A (pt) 1999-07-13
TR199801289T2 (en) 1998-10-21
CA2241993A1 (en) 1997-07-17
NO983090D0 (no) 1998-07-03
US6204249B1 (en) 2001-03-20
EA199800526A1 (ru) 1999-04-29
AP9801286A0 (en) 1998-09-30
CN1214049A (zh) 1999-04-14
JP2000515119A (ja) 2000-11-14
GB9600143D0 (en) 1996-03-06

Similar Documents

Publication Publication Date Title
MY117892A (en) Therapeutic compounds
CA2293470A1 (en) Benzimidazole derivatives
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
TNSN04113A1 (en) 3-â-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
MY107843A (en) Anti-viral compounds.
MY104043A (en) Therapeutic nucleosides.
MY104575A (en) Therapeutic nucleosides.
HUP0001170A3 (en) Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
MX9805441A (es) Compuestos terapeuticos.
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
MY104124A (en) Therapeutic compounds.
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
MY105855A (en) Therapeutic nucleotides.
HUP9900945A2 (hu) Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában
MY111746A (en) Therapeutic nucleosides.
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
MY106295A (en) Anti-infective nucleosides
CA2193665A1 (en) Benzimidazole derivatives for the treatment and prophylaxis of virus infections
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
MD1051C2 (ro) Remediu antiherpetic
MX9401370A (es) Terapia antiviral.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees